Clinical Trial Update: Atrial Fibrillation Screening With a Smartphone Device and iECG Application

View source ↗

Summary

A Bayer-sponsored trial evaluating smartphone-based atrial fibrillation screening with an iECG app has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Bayer | Conditions: Atrial Fibrillation | Status: WITHDRAWN